glp 1 agonist vs metformin GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Metformin and Glucagon-like peptide-1 (GLP-1)
Description
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
Multiple studies highlight its potential applications in prevention
Could addiction be next?
They might
How do bariatric surgery and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compare as obesity treatments regarding weight loss, ongoing costs, and health care utilization in a clinical setting
GLP-1 R from True Form Peptides offers 99% purity and HPLC verification
